Literature DB >> 16204310

Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.

Mingdong Zhang1, Philip S Rosenberg, Deborah L Brown, Liliana Preiss, Barbara A Konkle, M Elaine Eyster, James J Goedert.   

Abstract

People with hemophilia were formerly at very high risk of infection with hepatitis C virus (HCV). Approximately 20% of HCV-infected patients spontaneously clear the virus. To identify correlates of spontaneous clearance of HCV, we studied a cohort of HCV-infected hemophilic subjects without human immunodeficiency virus infection who had never been treated with interferon. Plasma HCV RNA was persistently undetectable in 192 (27.0%) of 712 HCV-seropositive subjects. In multivariate analyses, HCV clearance was more likely in subjects infected with HCV at younger age, especially with infection before age 2 years (40.1%) compared with after age 15 years (14.9%, P(trend) < .0001), and with relatively recent infection, especially after 1983 (42.8%) compared with before 1969 (18.2%, P(trend) < .0001). HCV clearance was marginally reduced with African ancestry (19%) and greatly increased with chronic hepatitis B virus (HBV) infection (59.1%, P = .001). Resolved HBV infection, coagulopathy types and severity, types of clotting factor treatment, and sex were not associated with HCV clearance. In conclusion, hemophilic subjects coinfected with chronic HBV and those infected with HCV before age 2 years or after 1983 were significantly more likely to spontaneously clear HCV viremia. These data highlight and clarify the importance of nongenetic determinants in spontaneous recovery from HCV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204310      PMCID: PMC1895891          DOI: 10.1182/blood-2005-07-2781

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Risk factors for infection with HBV and HCV in a largecohort of hemophiliac males.

Authors:  J M Soucie; L C Richardson; B L Evatt; J V Linden; B M Ewenstein; S F Stein; C Leissinger; M Manco-Johnson; C L Sexauer
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

2.  Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment.

Authors:  R Utili; R Zampino; P Bellopede; M Marracino; E Ragone; L E Adinolfi; G Ruggiero; M Capasso; P Indolfi; F Casale; A Martini; M T Di Tullio
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

3.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

Authors:  A Takaki; M Wiese; G Maertens; E Depla; U Seifert; A Liebetrau; J L Miller; M P Manns; B Rehermann
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

5.  Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.

Authors:  R Jardi; F Rodriguez; M Buti; X Costa; M Cotrina; R Galimany; R Esteban; J Guardia
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

Review 6.  Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.

Authors:  H J Alter; L B Seeff
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

7.  The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.

Authors:  M Franchini; G Rossetti; A Tagliaferri; F Capra; E de Maria; C Pattacini; G Lippi; G Lo Cascio; M de Gironcoli; G Gandini
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985.

Authors:  T T Yee; A Griffioen; C A Sabin; G Dusheiko; C A Lee
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

9.  Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Authors:  L B Seeff; F B Hollinger; H J Alter; E C Wright; C M Cain; Z J Buskell; K G Ishak; F L Iber; D Toro; A Samanta; R L Koretz; R P Perrillo; Z D Goodman; R G Knodell; G Gitnick; T R Morgan; E R Schiff; S Lasky; C Stevens; R Z Vlahcevic; E Weinshel; T Tanwandee; H J Lin; L Barbosa
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

10.  Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.

Authors:  Michael P Busch; Simone A Glynn; Susan L Stramer; Jennie Orland; Edward L Murphy; David J Wright; Steven Kleinman
Journal:  Transfusion       Date:  2006-03       Impact factor: 3.157

View more
  33 in total

1.  Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; Mohammad R Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Jerome H Kim; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Infect Dis       Date:  2010-12-28       Impact factor: 3.623

2.  Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.

Authors:  Tingting Li; Zixuan Chen; Jinfeng Zeng; Jingang Zhang; Wenjing Wang; Ling Zhang; Xin Zheng; Lifang Shuai; Paul Klenerman; Jean-Pierre Allain; Chengyao Li
Journal:  Biochem Biophys Res Commun       Date:  2011-10-29       Impact factor: 3.575

3.  Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Authors:  S M Gadalla; L R Preiss; M E Eyster; J J Goedert
Journal:  J Viral Hepat       Date:  2011-03       Impact factor: 3.728

4.  Spontaneous Clearance of the Hepatitis C Virus Among Men Who Have Sex With Men.

Authors:  Eric C Seaberg; Mallory D Witt; Lisa P Jacobson; Roger Detels; Charles R Rinaldo; Joseph B Margolick; Stephen Young; John P Phair; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-07-14       Impact factor: 9.079

5.  Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.

Authors:  Behzad Hajarizadeh; Bart Grady; Kimberly Page; Arthur Y Kim; Barbara H McGovern; Andrea L Cox; Thomas M Rice; Rachel Sacks-Davis; Julie Bruneau; Meghan Morris; Janaki Amin; Janke Schinkel; Tanya Applegate; Lisa Maher; Margaret Hellard; Andrew R Lloyd; Maria Prins; Ronald B Geskus; Gregory J Dore; Jason Grebely
Journal:  J Clin Virol       Date:  2014-09-08       Impact factor: 3.168

Review 6.  2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2018-08-10

Review 7.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 8.  Hepatitis C virus infection in the human immunodeficiency virus infected patient.

Authors:  Louise Nygaard Clausen; Lene Fogt Lundbo; Thomas Benfield
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

9.  Dynamics of HCV RNA levels during acute hepatitis C virus infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Tanya Applegate; Gail V Matthews; Janaki Amin; Kathy Petoumenos; Margaret Hellard; William Rawlinson; Andrew Lloyd; John Kaldor; Gregory J Dore
Journal:  J Med Virol       Date:  2014-07-08       Impact factor: 2.327

10.  The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.

Authors:  Jason Grebely; Kimberly Page; Rachel Sacks-Davis; Maarten Schim van der Loeff; Thomas M Rice; Julie Bruneau; Meghan D Morris; Behzad Hajarizadeh; Janaki Amin; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Janke Schinkel; Jacob George; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Maria Prins
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.